Sarah Js Glickman Criteo S.A. (CRTO) insider trading activity

Sarah Js Glickman is Chief Financial Officer of Criteo S.A.. Currently has a direct ownership of 361,190 shares of CRTO, which is worth approximately $8.38 Million. The most recent transaction as insider was on May 27, 2025, when has been sold 1,520 shares (Ordinary Shares) at a price of $26.12 per share, resulting in proceeds of $39,702. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 361K

1.09% 3M change

12.8% 12M change

Total Value Held $8.38 Million

Sarah JS Glickman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 27 2025	SELL Open market or private sale	$39,702 $26.12 p/Share	1,520 Reduced 0.42%	361,190 Ordinary Shares
May 23 2025	SELL Open market or private sale	$63,621 $25.81 p/Share	2,465 Reduced 0.68%	362,710 Ordinary Shares
Feb 28 2025	BUY Grant, award, or other acquisition	-	71,180 Added 16.31%	365,175 Ordinary Shares
Feb 25 2025	SELL Open market or private sale	$720,684 $40.3 p/Share	17,883 Reduced 5.73%	293,995 Ordinary Shares
Nov 25 2024	SELL Open market or private sale	$61,347 $40.36 p/Share	1,520 Reduced 0.49%	311,878 Ordinary Shares
Oct 23 2024	SELL Open market or private sale	$220,945 $40.6 p/Share	5,442 Reduced 1.71%	313,398 Ordinary Shares
Aug 26 2024	SELL Open market or private sale	$74,689 $49.17 p/Share	1,519 Reduced 0.47%	318,682 Ordinary Shares
Jul 23 2024	SELL Open market or private sale	$250,013 $45.49 p/Share	5,496 Reduced 1.69%	320,201 Ordinary Shares
May 24 2024	SELL Open market or private sale	$59,849 $38.99 p/Share	1,535 Reduced 0.47%	325,697 Ordinary Shares
Apr 23 2024	SELL Open market or private sale	$194,841 $35.4 p/Share	5,504 Reduced 1.65%	327,232 Ordinary Shares
Mar 01 2024	BUY Grant, award, or other acquisition	-	39,717 Added 10.66%	332,736 Ordinary Shares
Feb 26 2024	SELL Open market or private sale	$315,556 $32.69 p/Share	9,653 Reduced 3.19%	293,019 Ordinary Shares
Feb 23 2024	BUY Grant, award, or other acquisition	-	52,966 Added 14.89%	302,672 Ordinary Shares
Jan 23 2024	SELL Open market or private sale	$89,608 $24.74 p/Share	3,622 Reduced 1.43%	249,706 Ordinary Shares
Oct 23 2023	SELL Open market or private sale	$154,992 $28.16 p/Share	5,504 Reduced 2.13%	253,328 Ordinary Shares
Jul 24 2023	SELL Open market or private sale	$178,192 $32.63 p/Share	5,461 Reduced 2.07%	258,832 Ordinary Shares
Apr 24 2023	SELL Open market or private sale	$152,621 $30.27 p/Share	5,042 Reduced 1.87%	264,293 Ordinary Shares
Feb 23 2023	BUY Grant, award, or other acquisition	-	71,261 Added 20.92%	269,335 Ordinary Shares
Jan 23 2023	SELL Open market or private sale	$163,683 $28.95 p/Share	5,654 Reduced 2.78%	198,074 Ordinary Shares
Oct 24 2022	SELL Open market or private sale	$1,399,771 $26.05 p/Share	53,734 Reduced 20.87%	203,728 Ordinary Shares
Feb 24 2022	BUY Grant, award, or other acquisition	-	147,135 Added 36.37%	257,462 Ordinary Shares
Oct 23 2020	BUY Grant, award, or other acquisition	-	110,327 Added 50.0%	110,327 Ordinary Shares

Also insider at

ATR

APTARGROUP, INC. Healthcare

Director

TSVT

2seventy bio, Inc. Healthcare

BLUE

bluebird bio, Inc. Healthcare

Director

SJG